Objective. We sought to determine the association between plasma and SF levels of leptin and adiponectin in patients with knee OA.
Introduction
OA is the most widespread joint-affecting disease characterized by cartilage loss. A growing body of evidence suggests that OA is a systemic disorder of multifactorial origin that shares a similar biochemical and inflammatory profile to the metabolic syndrome [1] . Together with ageing and genetic factors, obesity is an important risk factor for OA, but the underlying mechanisms are not fully understood [2] . The increased mechanical loading across the articular cartilage is a logical explanation for the increased risk for OA in weight-bearing joints such as the knees. However, epidemiological studies have also shown an intriguing correlation between hand OA and obesity [3] . Since mechanical stress cannot explain such a correlation, metabolic factors have been suggested to play a significant role. Interestingly, hand OA in older women is also correlated with their degree of atherosclerosis, suggesting a connection between the two, independent of factors directly related to obesity [4] .
Adipocytes secrete adipokines such as leptin, adiponectin, visfatin and resistin, which exert regulatory activities on target tissues and cells involved in rheumatic diseases including OA (for a review see [5] ). These adipokines have been detected in the SF obtained from patients with OA [68] . Most clinical and experimental studies support a role of leptin and adiponectin as a non-mechanical link between obesity and OA.
In leptin-deficient and leptin receptor-deficient mice, extreme obesity did not increase the incidence of knee OA, suggesting that body fat per se may not be a risk factor for joint degeneration [9] . Leptin plays a catabolic role in cartilage metabolism, increasing the expression of several metalloproteinases (MMPs) [10, 11] . Interestingly, it has been shown that the obesity status of patients with OA might affect the responsiveness of cultured chondrocytes to leptin [12] . However, the steady-state levels of leptin are modulated by circulating levels of its soluble receptor (sOB-R) and higher total leptin concentration in plasma may not reflect the body's sensitivity to leptin because bound leptin is not active [13] . It has been shown that leptin and sOB-R expression is significantly increased in markedly damaged OA cartilage and in SF [14] . Therefore there is a possibility for a direct role of leptin in the pathophysiology of OA development and not an indirect involvement through its effect on obesity.
The role of adiponectin in OA is controversial since it has been shown to exert both protective and adverse effects in joints. In an animal model of OA, serum adiponectin levels are lower compared with the control group, suggesting a protective role in the development of the disease [15] . Moreover, adiponectin modulates cartilage destruction by upregulating tissue inhibitor of MMP-2 (TIMP-2) and downregulating MMP-13 in chondrocytes [16] . Conversely, adiponectin induces nitric oxide synthase type II and proinflammatory cytokines in chondrocytes [17] , while it causes matrix degradation in OA cartilage [18] .
Apart from proteins derived from plasma, SF contains additional molecules from the cells of adjacent joint tissues. Numerous proteomic studies have explored the existence of proteins specific for joint diseases in an attempt to provide useful insights into the pathogenesis of disease and identify relevant biomarkers. Such biomarkers cannot be expected to be abundant since local production from joint tissues takes place against a high background traffic of plasma proteins. Most candidate biomarkers are found in serum as well as SF, and the question arises whether their presence reflects passive exchange with plasma or local production and release [19] . Data on leptin, sOB-R and adiponectin levels in the plasma and SF of patients with knee OA, according to radiographic severity of disease, are scarce. Given the emerging role of leptin and adiponectin in OA, we sought to determine the association between plasma and SF levels of leptin and adiponectin with knee OA at different stages and whether these adipokines could be used as markers for disease severity.
Methods

Subjects
Ninety-six patients diagnosed with primary knee OA according to the criteria of the American Rheumatism Association [20] were consecutively recruited at the Academic Department of Orthopaedics of the University General Hospital of Alexandroupolis (Greece). Exclusion criteria were RA, post-traumatic arthritis, crystal deposition arthritis, PsA, enteropathic arthritis, avascular necrosis of the knee, haemophilic arthropathy, Charcot disease and any systemic inflammatory or autoimmune disorders. Knee radiographs were evaluated according to the modified Ahlback's grading scale [21] as follows: grade 1, narrowing of the articular space; grade 2, obliteration or almost obliteration of the articular space; grade 3, bone attrition < 5 mm; grade 4, bone attrition between 5 and 15 mm; grade 5, bone attrition >15 mm. All subjects participated after being informed about the study by their attending clinician and giving written consent. The study was approved by the ethics committee of the Scientific Council of the University General Hospital of Alexandroupolis and was in accordance with the Helsinki Declaration of Human Rights.
Laboratory methods
Apart from fasting blood, SF was obtained from all patients by arthrocentesis of the affected knee joints. SF was centrifuged to remove cells and joint debris and stored at À20 C until analysis. Plasma and SF concentrations of adipokines and sOB-R were quantitated by ELISA according to the manufacturer's instructions (human adiponectin ELISA kit, Millipore, USA; human leptin ELISA kit, Orgenium, Finland; human sOB-R ELISA kit, SPI-Bio, France). According to the manufacturers, the detection limits for adiponectin, leptin and sOB-R assays were 0.78 ng/ml, 62.5 pg/ml and 0.4 ng/ml, respectively. The inter-assay coefficients of variation for the three assays were <8.4%, <12% and <9.9%, respectively. Samples were diluted as appropriate and paired samples of plasma and SF were assayed in duplicate in the same run. The levels of plasma or SF free leptin were estimated by dividing respective concentrations of leptin by sOB-R.
Statistical analysis
Statistical analyses were performed using the Statistical Package for Social Sciences (SPSS 18.0 for Windows). Data were tested for normality by the KolmogorovSmirnov test. Normally distributed continuous variables are presented as mean (S.D.), whereas non-normally distributed continuous variables are presented as median (range). Comparisons for normally distributed continuous variables among stages of OA were performed with one-way analysis of variance. Non-normally distributed continuous variables were compared by MannWhitney test or KruskalWallis test as appropriate, whereas categorical variables were compared by 2 test.
Paired comparisons of variables between plasma and SF were performed by Wilcoxon's test. Bivariate associations between variables were examined using Spearman's correlation coefficient. Cluster analysis methods led to the definition of groups with similar values of certain attributes, such as laboratory variables (qualitative or quantitative analytes) or other variables (e.g. anthropometric) [22] . Using a matrix of distance measurements, cluster analysis finds groups of subjects more similar to each other than to those in other groups. The SPSS TwoStep cluster analysis is an algorithm that finds the optimal number of clusters using both continuous and categorical variables. In the present model, age, BMI and plasma leptin were included as continuous variables, whereas sex and stage of OA were categorical variables. Differences were considered statistically significant at a P-value of <0.05.
Results
Anthropometric and biochemical data are presented in Table 1 . Although the majority of recruited patients with knee OA were females (78.1%), there was no significant difference (P = 0.64) in the proportion of sexes across categories of OA severity. Age was significantly different across groups and post hoc analysis showed that this was due to a difference between subjects with OA stage 1 with 4 and 5 (P < 0.0001 for both differences) as well as those in OA stage 2 with 4 and 5 (P = 0.003 and P = 0.001, respectively). For all patients studied, adiponectin, leptin and sOB-R were significantly lower in SF compared with paired levels in plasma (P < 0.0001 for all variables). However, free leptin was significantly higher in SF compared with paired values in plasma (P < 0.0001). Plasma and SF levels of adiponectin, leptin, sOB-R and free leptin did not differ significantly across categories of OA severity. The above lack of differences remained when analysis was performed by sex (data not shown). However, the ratio of SF to plasma leptin was significantly lower in advanced OA stage compared with early stages of the disease (P = 0.02). When this analysis was performed by sex, the difference was significant only in female patients (P = 0.01).
In Table 2 , levels of adipokines, SF/plasma leptin, sOB-R and free leptin are presented according to sex. Male subjects had lower plasma adiponectin levels compared with female subjects, but this difference did not reach significance, whereas adiponectin levels in SF were similar in the two sexes. Leptin and free leptin in plasma and SF as well as the ratio of SF to plasma leptin were significantly higher in female compared with male subjects. Conversely, plasma and SF levels of sOB-R were significantly lower in female compared with male subjects.
There was no significant correlation between adipokines and sOB-R with age (results not shown). Plasma adiponectin was significantly associated with SF adiponectin (r = 0.39, P < 0.0001) but none of these was significantly associated with BMI. Table 3 shows the correlation matrix between BMI, leptin, SF/plasma leptin, sOB-R and free leptin. There was a positive association between BMI and leptin or free leptin in plasma and SF, whereas BMI was inversely correlated with sOB-R both in plasma and SF. However, there was no significant association between BMI and SF/plasma leptin. Similar correlations were observed when waist circumference was used as a measure of body habitus (results not shown). After adjustment for sex and BMI, plasma leptin positively correlated with categories of OA severity (r = 0.23, P = 0.02), whereas SF/plasma leptin negatively correlated with OA stage (r = À0.27, P = 0.01).
Cluster analysis was performed to further explore the association of plasma leptin with categories of OA severity (Table 4) . Patients were grouped in four clusters. Male patients were all included in cluster 4, had the lowest levels of plasma leptin and were distributed to all OA stages. Female patients were included in clusters 13 and had similar BMI across these clusters. Age and plasma leptin levels of female patients were highest in www.rheumatology.oxfordjournals.org cluster 1 and assigned to OA stages 4 and 5, whereas age and plasma leptin levels were lowest in cluster 3 and assigned to OA stages 1 and 2. Cluster 2 included female patients with age and plasma leptin values lying between clusters 1 and 3 and had stage 3 OA. Fig. 1 shows the within-cluster percentage of patients according to OA stage.
Discussion
Recent evidence suggests that knee OA is not a wear-and-tear condition, but is affected by systemic metabolic factors associated with obesity [23] . Adiponectin and leptin play an important role in energy homeostasis and metabolism, but recent clinical and experimental data also suggest their involvement in bone homeostasis and rheumatic disorders. In RA, although leptin is generally considered to be proinflammatory, it also has anabolic effects, such as stimulating the expression of cartilage growth factors and increasing proteoglycan synthesis [24] , which could explain its inverse association with radiographic joint damage [25] . Mice with leptin deficiency developed less severe arthritis compared with control mice [26] . However, leptin has been shown to exert mainly proinflammatory and catabolic properties in osteoarthritic joints, in agreement with the fact that women have both higher circulating leptin levels and a greater propensity to develop OA compared with men [27] . Leptin expression is much higher in OA cartilage than in normal cartilage and the level of leptin expression is associated with the degree of cartilage destruction [28] . Moreover, it has been shown that joint tissues, mainly osteophytes, infrapatellar fat pad and synovium, can secrete leptin into SF in OA [7] . Similarly, adiponectin is secreted mainly by synovium and infrapatellar fat pad, suggesting its involvement, in addition to leptin, in the pathophysiology of OA [7] . However, the effect of adiponectin on the pathogenesis of OA is more controversial since data suggest both an anabolic and catabolic role in OA. We hypothesized that there might be differences in these adipokines according to the severity of OA that could be useful as markers for disease severity. Leptin and adiponectin levels in SF were significantly lower than paired levels in plasma both in males and females, in agreement with the study by Gandhi et al. [29] and Presle et al. [7] , respectively. Conversely, bioactive leptin in SF was significantly higher compared with its plasma levels, in agreement with previous results [7] , suggesting its detrimental involvement in OA pathophysiology. Several studies have indicated the proinflammatory role of leptin in OA, since it induces production of MMPs, nitric oxide and proinflammatory cytokines [14, 30, 31] . However, we were unable to detect a significant difference of plasma and SF leptin levels or bioactive leptin across different stages of OA. This is in contrast to the study by Ku et al. [32] that assessed leptin levels only in SF according to OA severity and found SF leptin levels to be highest in patients in the most severe OA (grade 4; KellgrenLawrence classification). Although SF leptin levels are non-normally distributed, they employed parametric analysis to compare levels across groups, which could lead to erroneous results. The difference in our findings could also be due to the smaller number of OA patients in their study. According to our results, there was a trend for increasing levels of plasma leptin and decreasing SF leptin with increasing disease severity. Therefore we decided to assess the ratio of SF to plasma leptin across OA stages and found a significant decrease with increasing disease severity, attributable to female patients. The SF/plasma ratio of a single protein has been interpreted widely as evidence of the relative permeability of the synovial membrane to that protein. However, SF protein levels result from size-specific passive diffusion from plasma, local metabolism and clearance through synovial tissue lymphatics [33] . In joints affected by advanced OA compared with minimal disease, leptin SF levels could be modified by altered microvascular permeability due to inflammation, local synthesis or consumption and lymphatic drainage. Given the evidence for local production of leptin in OA joints and its deleterious effect on disease progression [7, 14] , it is more likely that the decreased SF/plasma ratio is due to changes in transport of leptin across the synovial membrane barrier rather than a decrease in leptin production by osteoarthritic tissues. It is possible that, with advancing OA, increased synovial permeability and/or increased lymphatic clearance could lead to lower leptin levels in SF. When arthritis supervenes, the fenestral pore of synovial microvessels appears to widen from 1.75 to 3.5 nm [19] , allowing leptin with a molecular radius of 1.81 nm [34] to cross the synovium more easily. Interestingly, leptin plays a critical role in the maintenance and regulation of vascular fenestrations in the adipose tissue while it induces a rapid vascular permeability response [35] . It was recently shown that increased vascular permeability associated with inflammation is not only limited to interendothelial gaps, but also that glycocalyceal damage and aquaporin upregulation may affect permeability in arthritic synovium [19] . There is evidence for variability in synovial microvascular permeability according to the type of arthritis. It has been shown that rheumatoid synovial tissues are more permeable to proteins than osteoarthritic synovial tissues [36] . However, lymphatic drainage is also greater in RA than it is in OA [37] , suggesting variability in articular protein traffic and caution in extrapolating results to RA.
In agreement with previous reports [6, 7] , male subjects had lower plasma adiponectin levels compared with female patients with OA. In a large sample of OA of the hands and knees, there was no evidence of an association between adiponectin and the presence of radiographic OA [38] . However, data on the association of plasma or SF adiponectin levels with OA severity are conflicting. It has been shown that adiponectin levels are increased in erosive OA compared with non-erosive OA, probably mediating matrix degradation [39] . On the contrary, another study demonstrated decreased adiponectin levels in both plasma and SF as the severity of OA increased [40] . Finally, although Chen et al. [16] showed that adiponectin upregulated TIMP-2 expression and partially abolished IL-1b-induced MMP-13 expression in chondrocytes, they were unable to demonstrate a significant association between plasma or SF adiponectin levels and severity of OA. Our results are in agreement with the latter study. The above discrepancies in results could be due to methodological issues regarding adiponectin quantitation. In future experiments it would be interesting to compare trimer, hexamer and high-molecular-weight adiponectin species among different OA stages. It has been shown that the expression of leptin in advanced OA cartilage significantly correlated with BMI values of the patients [14] . In our study, in agreement with previous reports, BMI positively correlated both with SF leptin [29] and free leptin [41] . Although both plasma and SF leptin were positively associated with BMI, the ratio of SF to plasma leptin was not associated with BMI, suggesting other factors that account for the distribution of leptin in the two compartments. Leptin may act as an inhibitory regulator of its receptors expression [14, 42] . The inverse association observed between leptin and sOB-R in plasma is in agreement with previous reports [43, 44] , and a similar but weaker association was observed in SF. Moreover, we confirm a negative association between sOB-R in SF and BMI [41] .
Clustering techniques are used when the data are expected to group physically in various categories. Clustering of OA patients was used to describe the patterns of disease based on the clinical, pathogenetic and physiological features. The analysis included five variables chosen to reflect putative mechanisms and clinical features of the different phenotypes. Since plasma leptin significantly associated with OA stage, it was included in the analysis along with sex, age and BMI, which are associated with disease occurrence and severity. All men were included in one cluster and distributed in different stages of OA independently of their characteristics. However, women formed three clusters with similar BMI but those who were older and had the highest plasma leptin levels suffered from advanced OA. Although cluster analysis has proved inefficient in identifying disease causes, its results may give insights into the structure of a data set and lead to hypotheses for further investigation. Undoubtedly, after validation of the structure found in the data set, the clinical benefit must be proven, including the repeatability of the cluster solutions in different samples [22] .
To our knowledge, our study included the largest number of patients with knee OA classified to different stages according to radiographic findings. However, the number of patients is still too small to draw definite conclusions on the association of leptin and adiponectin with different stages of knee OA. The finding of a decreased ratio of SF to plasma leptin in advanced stages of knee OA merits further investigation. It would be interesting to use an experimental design similar to the study by Presle et al. [7] in order to compare leptin secretion patterns in explants of joint tissues across OA stages. Moreover, further studies should investigate whether a similar association exists between the ratio of SF to plasma leptin and OA in other joints.
In conclusion, the ratio of SF to plasma leptin might be a marker related to the severity of knee OA. Prospective studies are warranted to investigate the role of leptin in the progression of OA. In order to confirm the significance of leptin as a marker of OA severity, investigations that monitor leptin levels in a prospective fashion when the earliest signs and symptoms of knee OA appear are needed. It is widely accepted that the surgical treatment of end-stage knee OA by joint reconstruction has become a heavy economic burden on both private and state health insurance and consequently early detection of OA using biomarkers could help clinicians provide timely intervention, reducing the need for arthroplasty.
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